← Back to patent-cliff list
CAS 113826-06-5
(R)-oxiran-2-ylmethyl 4-methylbenzenesulfonate
Codes：TEDI-013
Application context (from source-drug indications)
皮肤和皮肤结构感染泰地唑利磷酸盐葡萄球菌感染泰地唑利磷酸盐细菌性皮肤疾病泰地唑利磷酸盐
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 泰地唑利磷酸盐Tedizolid Phosphate | Tier C — Watch / trade | 2029 |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(R)-3-(3-fluoro-4-iodophenyl)-5-(hydroxymethyl)oxazolidin-2-one→5-bromo-2-(2H-tetrazol-5-yl)pyridine→2-fluoro-1-iodo-4-isocyanatobenzene→(R)-oxiran-2-ylmethyl 4-methylbenzenesulfonate→(R)-(3-(3-fluoro-4-iodophenyl)-2-oxooxazolidin-5-yl)methyl methanesulfonate→(R)-(3-(3-fluoro-4-iodophenyl)-2-oxooxazolidin-5-yl)methyl dihydrogen phosphate→(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)boronic acid→dimethyl (6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)boronate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.